BioTalent Canada Welcomes Federal Government’s Three-Year Extension of the Student Work Placement Program, Strengthening Canada’s Workforce and Economic Future BioTalent Canada has officially applauded the Government of Canada’s decision, announced…
Zai Lab Reports Promising Phase 1 Results for Zocilurtatug Pelitecan in Extensive-Stage Small Cell Lung Cancer, Launches Global Phase 3 Trial Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has released…
Pulse Biosciences Enrolls First Patient in NANOCLAMP AF Study, Marking Major Milestone in Atrial Fibrillation Treatment Innovation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company pioneering next-generation medical technologies through its…
Coya Therapeutics Prices Upsized $20 Million Public Offering to Advance Treg-Based Therapies for Neurodegenerative Diseases Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company pioneering biologic therapies designed to enhance…
Emalex Biosciences’ Expanded Access Program for Investigational Tourette Syndrome Therapy Receives FDA Authorization Emalex Biosciences, a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurodevelopmental and neurological disorders, today…
Orca Bio’s Orca-T Receives FDA Priority Review for Treatment of Blood Cancers, Marking Major Step Toward Potential First-in-Class Therapy Orca Bio, a late-stage biotechnology company pioneering high-precision cell therapies to…
Delta Dental of Tennessee Celebrates 60 Years with “60 Moments of Surprise Smiles” Campaign to Give Back to Communities Across the State Delta Dental of Tennessee (Delta Dental) is marking…
Aarvik Therapeutics Closes Series Seed 2 Financing Round, Accelerating Development of Next-Generation Cancer Therapies Aarvik Therapeutics, a pioneering biotechnology company specializing in antibody-drug conjugates (ADCs) and committed to advancing precision…
TAE Life Sciences’ Next-Generation Boron Drugs Show Promising Synergy with Immunotherapy in Preclinical BNCT Studies TAE Life Sciences (TLS), a leading biotechnology company focused on next-generation cancer therapies, today announced…
Versant Diagnostics Expands National Footprint with Strategic Partnership in Georgia, Strengthening Digital Pathology Access Versant Diagnostics (Versant), a pioneering independent physician services company specializing in digital anatomic pathology, has announced…
MindMed Study Highlights Alarmingly High Rates of Suicidal Ideation in Adults with Generalized Anxiety Disorder Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a late-stage clinical biopharmaceutical company pioneering innovative…
Candid Therapeutics Recognized as a 2025 Endpoints 11 Honoree, Highlighting Its Pioneering Work in T-Cell Engager Therapies Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company at the forefront of autoimmune…